References
Armitage JO, Bierman PJ, Vose JM, Anderson JR, Weisenburger DD, Kessinger A, Reed EC, Vaughan WP, Coccia PF, Purtilo DT (1991) Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med 91:605–611
Bodley Scott R, Robb-Smith AHT (1939) Histiocytic medullary reticulosis. Lancet 2:194
Borg-Grech A, Radford JA, Crowther D, Swindell R, Harris M (1989) A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. J Clin Oncol 7:1303–1309
Cohen JI (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 70:137–160
Craig FE, Clare CN, Sklar JL, Banks PM (1992) T-cell lymphoma and the virus-associated hemophagocytic syndrome. Am J Clin Pathol 97:189–194
Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C (1992) Histiocyte-rich B-cell lymphoma: a distinct clinicopathologic entity possibly related to lymphocyte-predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 16:37–48
Falini B, Pileri S, De Solàs I, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75:434–444
Hansmann ML, Stein H, Fellbaum C, Hui PF, Parwaresch MR, Lennert K (1989) Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 20:1169–1175
Henry-Amar M, Somers R (1990) Survival outcome after Hodgkin's disease: a report from the International Data Base on Hodgkin's disease. Semin Oncol 17:758–768
Henter JI, Elinder G, Öst Å, the FHL Study Group of the Histiocyte Society (1991) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29–33
Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Müller-Lantzsch N, Stein H (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766–4770
Jaffe ES (1988) Histiocytoses of lymph nodes: biology and differential diagnosis. Semin Diagn Pathol 5:376–390
Kadin ME, Glatstein E, Dorfman RF (1971) Clinicopathologic studies in 177 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer 27:1277–1294
Kadin ME, Kamoun M, Lamberg J (1981) Erythrophagocytic T-gamma lymphoma. A clinicopathologic entity resembling malignant histiocytosis. N Engl J Med 304:648–653
Kaplan HS (1980) Pathology. In: Kaplan HS (ed) Hodgkin's Disease, 2nd edn. Harvard University Press, Cambridge, pp 53–115
Kaplan HS (1980) Clinical evaluation. In: Kaplan HS (ed) Hodgkin's disease, 2nd edn. Harvard University Press, Cambridge, pp 117–145
Kaplan HS (1980) Patterns of anatomic distribution. In: Kaplan HS (ed) Hodgkin's disease, 2nd edn. Harvard University Press, Cambridge, pp 280–339
Kaplan HS (1980) Prognosis. In: Kaplan HS (ed) Hodgkin's disease, 2nd edn. Harvard University Press, Cambridge, pp 548–597
Kim HD, Hendrickson MR, Dorfman RF (1977) Composite lymphoma. Cancer 40:959–976
Klein G (1992) Epstein-Barr virus-carrying cells in Hodgkin's disease. Blood 80; 299–301
Klimo P, Connors JM (1988) An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV hybrid program. Semin Hematol 25 [Suppl 2]: 34–40
Kluin-Nelemans JC, Noordijk EM (1990) Editorial: Staging of patients with Hodgkin's disease: what should be done? Leukemia 4:132–135
Korman LY, Smith JR, Landaw SA, Davey FR (1979) Hodgkin's disease: intramedullary phagocytosis with pancytopenia. Ann Intern Med 91:60–61
Lennert K, Hansmann ML (1978) Progressive transformation of germinal centers: clinical significance and lymphocytic predominance Hodgkin's disease: the Kiel experience. Am J Surg Pathol 11:149–150
Loy TS, Diaz-Arias AA, Perry MC (1991) Familial erythrophagocytic lymphohistiocytosis. Semin Oncol 18:34–38
Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063–1083
Lukes RJ, Collins RD (1992) Tumors of the hematopoietic system. AFIP, Washington
Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P (1966) Report on the momenclature committee. Cancer Res 26:1311
Miettinen M, Franssila KO, Saxen E (1983) Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer 51:2293–2300
Moran EM, Ultmann JE (1974) Clinical features and course of Hodgkin's disease. In: Rosenberg SA (ed) Hodgkin's disease and other lymphomas. Saunders, London, pp 91–129
Nalesnik MA (1991) Lymphoproliferative disease in organ transplant recipients. Springer Semin Immunopathol. 13:199–216
Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320–322
Press OW, Livingston R, Mortimer J, Collins C, Appelbaum F (1991) Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. J Clin Oncol 9:423–431
Purtilo DT, Stevenson M (1991) Lymphotropic viruses as etiologic agents of lymphoma. Hematol Oncol Clin North Am 5:901–923
Reiner A, Spivak JL (1988) Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 67:369–388
Reznek RH, Richards MA (1987) The radiology of lymphoma. In: McElwain TJ, Lister TA (eds) Clinical haematology: the lymphomas. Ballière Tindall, London, pp 77–107
Rijswijk REN, Sybesma JPHB, Kater L (1983) A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease. Cancer 51:637–644
Risdall RJ, McKenna RW, Nesbit ME, Drivit W, Balfour HH jr, Simmons RL, Brunning RD (1979) Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993–1002
Rosner F, Grünwald HW (1984) Association of T-cell acute lymphoblastic leukemia and histiocytic medullary reticulosis. Am J Med 77:910–914
Somers R, Henry-Amar M, Meerwaldt JH, Carde P (1990) Treatment strategy in Hodgkin's disease, John Libbey Eurotext, London
Sundeen JT, Cossman J, Jaffe ES (1988) Lymphocyte-predominant Hodgkin's disease nodular subtype with coexistent “large cell lymphoma”. Am J Surg Pathol 12:599–606
Swerdlow SH (1992) Hodgkin's disease. In: Silverberg SG (ed) Biopsy interpretation of lymph nodes. Raven, New York, p 301
Swerdlow SH (1992) Histiocytic and other non-lymphoid proliferations. In: Silverberg SG (ed) Biopsy interpretation of lymph nodes. Raven, New York, pp 342–368
Timens W. Visser L, Poppema S (1986) Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest 54:457–461
Trudel MA, Krikorian JG, Neiman RS (1987) Lymphocyte predominance Hodgkin's disease. A clinicopathologic reassessment. Cancer 59:99–106
Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76–81
Warnke RA, Kim H, Dorfman RF (1975) Malignant histiocytosis (histiocytic medullary reticulosis). I. Clinicopathologic study of 29 cases. Cancer 35:215–230
Wilson MS, Weiss LM, Gatter KC, Mason DY, Dorfman RF, Warnke RA (1990) Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 66:530–536
Zijlmans JMJM, Van Rijthoven AWAM, Kluin PhM, Jiwa NM, Dijkmans BAC, Kluin-Nelemans JC (1992) Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine. N Engl J Med 326:1363–1363
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kluin-Nelemans, J.C., Kluin, P.M. & Bieger, R. A 26-year-old man with Hodgkin's disease and rapidly progressive pancytopenia. Ann Hematol 67, 49–56 (1993). https://doi.org/10.1007/BF01709667
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01709667